Gemifloxacin [gemifloxacin]
topical
- Terms
-
Factive
gemifloxacin mesylát
-
7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid
Factive
Gemifloxacin Mesylate
LB 20304
LB-20304
LB20304
SB 265805
SB-265805
Persistent link
https://www.medvik.cz/link/D000077735
Definition
A naphthyridine and fluoroquinolone derivative antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used for the treatment of community-acquired pneumonia and acute bacterial infections associated with chronic bronchitis.
- DUI
- D000077735 MeSH Browser
- CUI
- M0370050
- CAS
- 1,8-Naphthyridine-3-carboxylic acid, 7-((4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-
- History note
- 2019 (1997)
- Public note
- 2019; GEMIFLOXACIN was indexed under NAPHTHYRIDINES and FLUOROQUINOLONES 1997-2018
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D03.633.100.612.250
Gemifloxacin
D03.633.100.810.835.830.250.316
Gatifloxacin
D03.633.100.810.835.830.250.322
Gemifloxacin